Announcements Trials
Browse Landscape

Phase

Phase 2 931Phase 3 619Phase NA 189Phase 1 185Phase 1/2 83Phase 2/3 40Phase 4 12Phase EARLY_PHASE1 5

Status

Completed 2Withdrawn 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1597INDUSTRY 233OTHER_GOV 26NIH 24INDIV 6NETWORK 5FED 2

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 2Genitourinary 2Thoracic 1Gastrointestinal 1Breast 1

Conditions

Prostatic Neoplasms 2Plasmablastic Lymphoma 1Neoplasms 1Lymphoma, B-Cell 1Lung Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1

Interventions

venetoclax 1tafasitamab 1relugolix 1prednylidene 1glofitamab 1deltacortene 1daratumumab 1Vincristine 1Rituximab 1Prednisone 1Gemcitabine 1Etoposide 1Doxorubicin 1Dexamethasone 1Cyclophosphamide 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × NETWORK × Clear all
NCT04161248 2026-05-12

Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma

Canadian Cancer Trials Group

Phase EARLY_PHASE1 Active not recruiting
40 enrolled
Lymphoid

Lymphoma, B-Cell

NCT06520449 2025-09-25

NTA-476

Melbourne Theranostic Innovation Centre

Phase EARLY_PHASE1 Completed
10 enrolled
Genitourinary

Prostatic Neoplasms

NCT07069465 2025-07-16

PIONEER PSMA

Urology Clinics of North Texas

Phase EARLY_PHASE1 Completed
10 enrolled
Genitourinary

Prostatic Neoplasms

NCT04139304 2025-06-29

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

AIDS Malignancy Consortium

Phase EARLY_PHASE1 Recruiting
15 enrolled
Lymphoid

Plasmablastic Lymphoma

NCT00606970 2013-05-07

Safety Assessment of Lactobacillus Fermented Extract in Cancer Patients Undergoing Chemotherapy

New Hope Medical Center

Phase EARLY_PHASE1 Withdrawn
BreastGastrointestinalThoracic

Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡